Business brief
FTSE Oncology Bets, City Takeover Fees, and Regulatory Crackdowns
AstraZeneca wagers $2B on bispecific oncology, City advisory desks harvest £1.2B from inbound takeovers, and the CMA accelerates drip-pricing enforcement.
Business
City advisory desks are booking record profits by selling off undervalued British companies — pocketing fees while the London market shrinks beneath them.
BackgroundLondon-listed equities have traded at persistent valuation discounts against US peers since 2016, making FTSE 250 mid-caps prime targets for foreign acquisitions. The resulting takeover wave has triggered political debate in Westminster over the hollowing out of Britain's public equity markets.
- London Stock Exchange data indicates total transaction value targeting British firms more than doubled, led by 14 takeovers guided by JPMorgan worth £67.6 billion.
- Top City law firms including Slaughter and May pocketed record retainers, driving renewed scrutiny over executive compensation and banking bonus regulations.
- The delisting of domestic engineering, technology, and consumer businesses continues to erode the capital base of the London Stock Exchange, limiting local pension investment options.
Business
Ken Murphy is selling off Tesco's last international units to German discounter Lidl — consolidating cash to defend the supermarket's dominant UK grocery perimeter.
BackgroundTesco spent two decades building extensive retail footprints across Central Europe and Asia before costly competitive battles forced widespread overseas disposals. The supermarket recorded a £75 million impairment against its Slovakian unit as German discounters Lidl and Aldi squeezed profit margins.
- Schwarz Group is reviewing store assets across Prague and Bratislava to expand its discount retail dominance across Eastern Europe, challenging remaining regional incumbents.
- Tesco analysts project resilient UK core food sales for H1, offsetting rising national insurance and wage overheads across British distribution hubs.
- Divesting the final European supermarket assets will leave Tesco almost entirely focused on defending its 28.2% UK grocery market share against expanding discounters.
Business
AstraZeneca invested $2 billion to lock down trial access to ivonescimab — securing a next-generation cancer partner while protecting its own lucrative ADC pipeline.
BackgroundIvonescimab, which targets both PD-1 and VEGF pathways, recently beat Merck's dominant Keytruda in clinical trials, sparking fierce interest from legacy pharmaceutical majors. AstraZeneca is seeking to maintain its global oncology leadership as patent exclusivities on earlier-generation cancer therapies expire.
- The preferred shares were transacted at $18.36, representing an 18.6% premium over Summit's recent average price and injecting substantial non-dilutive liquidity into clinical development.
- The companies will split clinical costs to evaluate ivonescimab alongside AstraZeneca's ADC sonesitatug vedotin in gastrointestinal malignancies, accelerating trial enrollment across Europe and North America.
- Both drugmakers retain independent commercial rights across existing geographies, eliminating standard milestone disputes or complex royalty splits that frequently delay global drug commercialisation.
Business
The CMA is using its new statutory powers to stamp out hidden fees before 2027 — forcing consumer booking apps to show the true total cost up front.
BackgroundDrip pricing occurs when businesses advertise an incomplete headline price before tacking on unavoidable booking fees or service charges at checkout. Under the Digital Markets, Competition and Consumers Act, the CMA can directly fine non-compliant firms up to 10% of global turnover.
- Investigators are targeting booking charges of up to £2.79 on rail journeys and unbundled resort fees added to package holidays, requiring transparent upfront pricing.
- Downing Street accelerated the statutory compliance deadline to January 2027, cutting transition windows for recurring subscription businesses and digital ticketing platforms.
- The direct administrative fining regime forces retail and travel operators to overhaul digital checkouts or face punitive financial penalties without High Court appeal delays.
Business
Business
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
